Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy
Clinical trial NCT04173442 · COMPLETED
Trial details
- NCT number
- NCT04173442
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-10-24
- Primary completion
- 2025-11-04
- Enrollment
- 581
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.